Lila Sanning, MD
banner
lilamd.bsky.social
Lila Sanning, MD
@lilamd.bsky.social
Neonatologist-Scientist at Wash U Medicine in St. Louis • Investigating host-microbe interactions •
Very happy to share our latest work in @bloodadvances.bsky.social: Antibiotic treatment limits survival of peripheral and bone marrow B-cell populations ashpublications.org/bloodadvance...
October 25, 2025 at 9:32 PM
Reposted by Lila Sanning, MD
Exciting energy from the next generation of physician-scientists at the 2025 @washumedicine.bsky.social Pediatric
Research Retreat! 🚀 Early career faculty are driving innovation across disciplines. The future of child health research is bright! 🌟#PedsResearch #AcademicMedicine #FutureLeaders #WashU
April 5, 2025 at 1:12 AM
Reposted by Lila Sanning, MD
Out now! Live bacteria can translocate to other tissues via Colonic goblet cell-associated passages which may be beneficial to the host!

#MicroSky #MicrobiomeSky 🦠

www.nature.com/articles/s41...
Colonic goblet cell-associated antigen passages mediate physiologic and beneficial translocation of live gut bacteria in preweaning mice - Nature Microbiology
Colonic goblet cell-associated passages allow translocation of live bacteria to other organs in early life, potentially leading to beneficial impacts.
www.nature.com
April 4, 2025 at 2:09 AM
Reposted by Lila Sanning, MD
It’s #MucosalMonday and time for our monthly podcast. This episode features @cjohansson-lab.bsky.social, along with hosts @marionbrunck.bsky.social and @ashu-mangalam.bsky.social. Find it on your favorite platform, including spotify: open.spotify.com/episode/4Ng1...
Adding insult to injury during RSV infections
Mucosal Immunology Podcast · Episode
open.spotify.com
March 24, 2025 at 3:59 PM
Reposted by Lila Sanning, MD
In the US alone, each year, norovirus causes ~20 million acute gastroenteritis cases, 70,000 hospitalizations, up to 800 deaths, at a cost of ~$10.6 billion annually.
An pill vaccine shows considerable promise in a clinical trial, establishing mucosal immunity
www.science.org/doi/10.1126/...
An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial
An oral norovirus vaccine tablet is safe and induces strong mucosal and systemic immune responses in adults aged 55 to 80 years.
www.science.org
March 6, 2025 at 12:02 AM
Just joined @bsky.app! Looking forward to connecting with neonatology & scientific communities on this platform.
December 10, 2024 at 10:29 PM